Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Serotonin regulates osteoclast differentiation through its transporter.

Battaglino R, Fu J, Späte U, Ersoy U, Joe M, Sedaghat L, Stashenko P.

J Bone Miner Res. 2004 Sep;19(9):1420-31. Epub 2004 Jun 21.

3.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
4.

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.

Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O.

Blood. 2003 May 1;101(9):3451-9. Epub 2003 Jan 2.

6.
7.

Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.

Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.

J Cell Physiol. 2004 Oct;201(1):17-25.

PMID:
15281085
8.

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

Valverde P, Tu Q, Chen J.

J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.

10.

Approach to novel functional foods for stress control 4. Regulation of serotonin transporter by food factors.

Ito M, Haito S, Furumoto M, Kawai Y, Terao J, Miyamoto K.

J Med Invest. 2005 Nov;52 Suppl:245-8.

11.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

12.

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.

Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.

J Bone Miner Res. 2004 Nov;19(11):1873-81. Epub 2004 Aug 16.

13.

Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.

J Bone Miner Res. 2000 Aug;15(8):1459-66.

15.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

16.

Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.

Smith R, Ransjö M, Tatarczuch L, Song SJ, Pagel C, Morrison JR, Pike RN, Mackie EJ.

J Bone Miner Res. 2004 Mar;19(3):507-16. Epub 2003 Dec 22.

17.

12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.

Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.

J Bone Miner Res. 2003 Dec;18(12):2159-68.

18.
19.

Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.

Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, Tanaka S, Kim HM, Kim HH, Lee ZH.

Blood. 2005 Apr 1;105(7):2963-9. Epub 2004 Dec 7.

20.

Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.

Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H.

J Exp Med. 2003 Apr 21;197(8):1029-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk